ZYPREXA

Product NDC: 0002-7597
11-digit product format: 000027597
Labeler code: 0002
Product ID: 0002-7597_9073f34c-307c-4a3a-8273-580ef5742229
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Olanzapine
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAMUSCULAR
Labeler: Eli Lilly and Company
Application: NDA021253
Marketing category: NDA
Marketing start: 2004-04-01
Marketing end: 2026-06-30
Substance: OLANZAPINE
Active strength: 10 mg/2mL
Pharmacologic classes: Atypical Antipsychotic [EPC]
NDC exclude flag: No
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0002-7597		D	Discontinued by firm		2026-08-07
excluded package	package	0002-7597	0002-7597-01	D	Discontinued by firm		2026-08-07

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021253-001	ZYPREXA	OLANZAPINE	10MG/VIAL	POWDER / INTRAMUSCULAR	AP	RLD, RS	2004-03-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N021253-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021253-001	ZYPREXA	10MG/VIAL	POWDER / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021253-001	ZYPREXA	10MG/VIAL	INJECTABLE / INTRAMUSCULAR	AP	RLD, RS	2004-03-29	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021253-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021253-001	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021253-001	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021253-001	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021253-001	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021253-001	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021253-001	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021253-001	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021253-001	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021253-001	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021253-001	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021253-001	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021253-001	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021253-001	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021253-001	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021253-001	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021253-001	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021253-001	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021253-001	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021253-001	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021253-001	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021253-001	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021253-001	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021253-001	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021253-001	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021253-001	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021253-001	AP	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021253-001	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021253-001	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021253-001	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021253-001	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021253-001	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021253-001	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021253-001	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021253-001	AP	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021253-001	AP	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021253-001	AP	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021253-001	AP	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021253-001	AP	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021253-001	AP	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
42e9462d-db65-453b-8069-8fb2df9182e8	Product name	1	20211216
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
12d02c27-e8da-47f1-b815-ccca982731ef	Product name	9	20170802
877783eb-030c-6e3f-0979-804cf94d8856	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0002-7597-01	ZYPREXA Intramuscular	1 in 1 CARTON	INJECTION, POWDER, FOR SOLUTION	1		67
0002-7597-01	ZYPREXA Intramuscular	2 mL in 1 VIAL	INJECTION, POWDER, FOR SOLUTION	2		67

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0002-7597-01	EA - Each	0002-7597	659a6fb4-1a17-4371-9476-3366a8ecca77	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Olanzapine	ACTIVE INGREDIENT	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Olanzapine	ACTIVE MOIETY	N7U69T4SZR	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Aspartame	INACTIVE INGREDIENT	Z0H242BBR1	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Carnauba wax	INACTIVE INGREDIENT	R12CBM0EIZ	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Crospovidone	INACTIVE INGREDIENT	68401960MK	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Ferric Oxide Red	INACTIVE INGREDIENT	1K09F3G675	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Gelatin	INACTIVE INGREDIENT	2G86QN327L	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Hydrochloric acid	INACTIVE INGREDIENT	QTT17582CB	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Lactose	INACTIVE INGREDIENT	J2B2A4N98G	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Lactose monohydrate	INACTIVE INGREDIENT	EWQ57Q8I5X	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Mannitol	INACTIVE INGREDIENT	3OWL53L36A	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Methylparaben Sodium	INACTIVE INGREDIENT	CR6K9C2NHK	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Polyethylene glycol 4000	INACTIVE INGREDIENT	4R4HFI6D95	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Propylparaben Sodium	INACTIVE INGREDIENT	625NNB0G9N	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Tartaric acid	INACTIVE INGREDIENT	W4888I119H	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45
Triacetin	INACTIVE INGREDIENT	XHX3C3X673	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	45

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0002-7597	ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]	66	Current NDC, Legacy NDC, 2 package rows	20250110_d5051fbc-846b-4946-82df-341fb1216341.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Zyprexa	OLANZAPINE	H2-Pharma LLC	b418946a-1ab4-4d89-a012-d94fc361a3c4	2026-02-11	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 021253 application number: NDA021253

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
N7U69T4SZR	OLANZAPINE	132539-06-1	OLANZAPINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
312076	OLANZapine 10 MG Disintegrating Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
485968	OLANZapine 10 MG Injection	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
314154	OLANZapine 10 MG Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
351107	OLANZapine 15 MG Disintegrating Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
312077	OLANZapine 15 MG Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
200034	OLANZapine 2.5 MG Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
351108	OLANZapine 20 MG Disintegrating Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
283639	OLANZapine 20 MG Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
314155	OLANZapine 5 MG Disintegrating Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
312078	OLANZapine 5 MG Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
312079	OLANZapine 7.5 MG Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
545353	ZyPREXA 10 MG Injection	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
153048	ZyPREXA 10 MG Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
261337	ZyPREXA 15 MG Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
212405	ZyPREXA 2.5 MG Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
284514	ZyPREXA 20 MG Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
153046	ZyPREXA 5 MG Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
153047	ZyPREXA 7.5 MG Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
754503	ZyPREXA ZYDIS 10 MG Disintegrating Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
754504	ZyPREXA ZYDIS 15 MG Disintegrating Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
754505	ZyPREXA ZYDIS 20 MG Disintegrating Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
754506	ZyPREXA ZYDIS 5 MG Disintegrating Oral Tablet	PSN	d5051fbc-846b-4946-82df-341fb1216341	67
754503	olanzapine 10 MG Disintegrating Oral Tablet [Zyprexa]	SBD	d5051fbc-846b-4946-82df-341fb1216341	67
545353	olanzapine 10 MG Injection [Zyprexa]	SBD	d5051fbc-846b-4946-82df-341fb1216341	67
153048	olanzapine 10 MG Oral Tablet [Zyprexa]	SBD	d5051fbc-846b-4946-82df-341fb1216341	67
754504	olanzapine 15 MG Disintegrating Oral Tablet [Zyprexa]	SBD	d5051fbc-846b-4946-82df-341fb1216341	67
261337	olanzapine 15 MG Oral Tablet [Zyprexa]	SBD	d5051fbc-846b-4946-82df-341fb1216341	67
212405	olanzapine 2.5 MG Oral Tablet [Zyprexa]	SBD	d5051fbc-846b-4946-82df-341fb1216341	67
754505	olanzapine 20 MG Disintegrating Oral Tablet [Zyprexa]	SBD	d5051fbc-846b-4946-82df-341fb1216341	67
284514	olanzapine 20 MG Oral Tablet [Zyprexa]	SBD	d5051fbc-846b-4946-82df-341fb1216341	67
754506	olanzapine 5 MG Disintegrating Oral Tablet [Zyprexa]	SBD	d5051fbc-846b-4946-82df-341fb1216341	67
153046	olanzapine 5 MG Oral Tablet [Zyprexa]	SBD	d5051fbc-846b-4946-82df-341fb1216341	67
153047	olanzapine 7.5 MG Oral Tablet [Zyprexa]	SBD	d5051fbc-846b-4946-82df-341fb1216341	67
312076	olanzapine 10 MG Disintegrating Oral Tablet	SCD	d5051fbc-846b-4946-82df-341fb1216341	67
485968	olanzapine 10 MG Injection	SCD	d5051fbc-846b-4946-82df-341fb1216341	67
314154	olanzapine 10 MG Oral Tablet	SCD	d5051fbc-846b-4946-82df-341fb1216341	67
351107	olanzapine 15 MG Disintegrating Oral Tablet	SCD	d5051fbc-846b-4946-82df-341fb1216341	67
312077	olanzapine 15 MG Oral Tablet	SCD	d5051fbc-846b-4946-82df-341fb1216341	67
200034	olanzapine 2.5 MG Oral Tablet	SCD	d5051fbc-846b-4946-82df-341fb1216341	67
351108	olanzapine 20 MG Disintegrating Oral Tablet	SCD	d5051fbc-846b-4946-82df-341fb1216341	67
283639	olanzapine 20 MG Oral Tablet	SCD	d5051fbc-846b-4946-82df-341fb1216341	67
314155	olanzapine 5 MG Disintegrating Oral Tablet	SCD	d5051fbc-846b-4946-82df-341fb1216341	67
312078	olanzapine 5 MG Oral Tablet	SCD	d5051fbc-846b-4946-82df-341fb1216341	67
312079	olanzapine 7.5 MG Oral Tablet	SCD	d5051fbc-846b-4946-82df-341fb1216341	67
545353	Zyprexa 10 MG Injection	SY	d5051fbc-846b-4946-82df-341fb1216341	67
153048	Zyprexa 10 MG Oral Tablet	SY	d5051fbc-846b-4946-82df-341fb1216341	67
261337	Zyprexa 15 MG Oral Tablet	SY	d5051fbc-846b-4946-82df-341fb1216341	67
212405	Zyprexa 2.5 MG Oral Tablet	SY	d5051fbc-846b-4946-82df-341fb1216341	67
284514	Zyprexa 20 MG Oral Tablet	SY	d5051fbc-846b-4946-82df-341fb1216341	67
754506	Zyprexa 5 MG Disintegrating Oral Tablet	SY	d5051fbc-846b-4946-82df-341fb1216341	67
153046	Zyprexa 5 MG Oral Tablet	SY	d5051fbc-846b-4946-82df-341fb1216341	67
153047	Zyprexa 7.5 MG Oral Tablet	SY	d5051fbc-846b-4946-82df-341fb1216341	67
754503	Zyprexa Zydis 10 MG Disintegrating Oral Tablet	SY	d5051fbc-846b-4946-82df-341fb1216341	67
754504	Zyprexa Zydis 15 MG Disintegrating Oral Tablet	SY	d5051fbc-846b-4946-82df-341fb1216341	67
754505	Zyprexa Zydis 20 MG Disintegrating Oral Tablet	SY	d5051fbc-846b-4946-82df-341fb1216341	67
754506	Zyprexa Zydis 5 MG Disintegrating Oral Tablet	SY	d5051fbc-846b-4946-82df-341fb1216341	67
485968	OLANZapine 10 MG Injection	PSN	85688d8f-f2de-408a-8ae2-0976c266c961	2
545353	ZyPREXA 10 MG Injection	PSN	85688d8f-f2de-408a-8ae2-0976c266c961	2
545353	olanzapine 10 MG Injection [Zyprexa]	SBD	85688d8f-f2de-408a-8ae2-0976c266c961	2
485968	olanzapine 10 MG Injection	SCD	85688d8f-f2de-408a-8ae2-0976c266c961	2
545353	Zyprexa 10 MG Injection	SY	85688d8f-f2de-408a-8ae2-0976c266c961	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0002-7597-01	00002759701	1 VIAL in 1 CARTON (0002-7597-01) / 2 mL in 1 VIAL	1 vial	2004-04-01	2026-06-30	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Zyprexa	Eli Lilly and Company	2025-11-18	HUMAN PRESCRIPTION DRUG LABEL	67
ZYPREXA Intramuscular	TYA Pharmaceuticals	2016-05-18	HUMAN PRESCRIPTION DRUG LABEL	2